LCMS webinars focusing on LC/TOF - page 48

In this webinar will show the application and limitations of HT timsTOF Pro MS on large scale clinical sample sets in order to stratify patients and contribute to a multi-omics blood atlas of COVID-19 patients.

In this presentation we present several mass spectrometry-based technologies used in a stage appropriate manner to dramatically shorten timelines and improve throughput in biologics research.

In this webinar, we will talk about how the BioAccord LC-MS system has helped users analyze a diverse range of modified oligonucleotides and known impurities using the compliance-ready workflow.

The talk will present on two specific areas of developments in Ion Mobility - Mass Spectrometry. Structural differences in native proteins and also focusing on the achievements in high resolution ion mobility.

The chemical composition of e-liquids for electronic cigarettes has been evaluated since 2015, using TOF MS, HS-GC-FID, GC-MS, and LC-MS/MS.

This webinar highlights a workflow to characterize AAVs (Adeno-associated viruses) via LC/MS, including post-translational modification identification of the capsid proteins.

In this webinar we will demonstrate an automated LC/MS workflow to quantify intact mAb drugs in mouse plasma. The workflow uses an Agilent AssayMAP Bravo and an Agilent 6545XT AdvanceBio LC/Q-TOF system.

Host cell protein analysis by SWATH LC-MS is overcoming several of ELISA method challenges and has multiple advantages for identification and quantification of HCP and manufacturing process related impurities.

In this webinar, we will talk about recent work demonstrating the utility of the BioAccord LC-MS system and find out how this system has helped users analyze and monitor oligonucleotides and known impurities.

This webinar will demonstrate Bruker’s fully integrated lipidomics workflow in MetaboScape and outline how novel 4D-lipidomics tools has been used to gain a better understanding the fountain of youth :-)